Sign In
Buy BCRX
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Tuesday Afternoon Analyst Upgrades and Downgrades: Exxon Mobil, First Solar, Tesla and More
12:36pm, Tuesday, 03'rd Aug 2021
With the trading day more than halfway over, the broad markets were pushing higher yet again.
3 Biotech Stocks That Could Rocket Higher
06:37am, Saturday, 24'th Jul 2021
Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.
BioCryst to Report Second Quarter 2021 Financial Results on August 5
07:00am, Thursday, 22'nd Jul 2021
RESEARCH TRIANGLE PARK, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2021 financial results on
BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
11:04pm, Wednesday, 21'st Jul 2021
BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
09:41am, Thursday, 15'th Jul 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has announced the designs for REDEEM-1 and REDEEM-2, two upcoming pivotal trials for its oral Factor D inhibitor, BCX9930, in patients with paroxysmal no
BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks
07:04am, Monday, 12'th Jul 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has announced 96-week data from the Phase 3 APeX-2 trial for Orladeyo (berotralstat), showing a sustained reduction in hereditary angioedema (HAE) attack
BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline
10:00am, Saturday, 10'th Jul 2021
—Multiple data presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2021 highlight durability of effect and long-term safety of ORLADEYO— —Multiple da
ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
04:15pm, Thursday, 01'st Jul 2021
RESEARCH TRIANGLE PARK, N.C., July 01, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced multiple upcoming data presentations at the European Academy of Allergy an
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
02:24am, Wednesday, 30'th Jun 2021
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
Up 126% in 2021, Could BioCryst Pharmaceuticals Go Even Higher?
07:31am, Tuesday, 29'th Jun 2021
There's more than one opportunity for it to do so.
BioCryst Announces Acceptance and Accelerated Review of the ORLADEYO™ (berotralstat) Marketing Application by the Israeli Ministry of Health
07:00am, Wednesday, 16'th Jun 2021
— Neopharm Ltd. selected as exclusive distribution and supply partner of ORLADEYO in Israel — — Neopharm Ltd. selected as exclusive distribution and supply partner of ORLADEYO in Israel —
7 A-Rated Biotech Stocks to Buy Now
11:06am, Tuesday, 15'th Jun 2021
Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios. The post 7 A-Rated Biotech Stocks to Buy Now appeared first on Inv
BioCryst Pharmaceuticals: An Orphan Disease Innovator With More Upside
01:11pm, Thursday, 10'th Jun 2021
BioCryst Pharmaceuticals: An Orphan Disease Innovator With More Upside
Forget AMC, GameStop: Analyst Names 2 New Reddit Stocks Traders Should Watch
02:02pm, Thursday, 27'th May 2021
Meme stocks AMC Entertainment Holdings Inc (NYSE: AMC) and GameStop Corp. (NYSE: GME) are on the move once again this week, fueled by targeted buying campaigns driven by Reddit's WallStreetBets commun
Is BioCryst a Good Stock to Buy Now?
06:27am, Friday, 21'st May 2021
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
